Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin P Alyea

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
Best Practice & Research. Clinical Haematology|May 28, 2008
Modulating graft-versus-host disease to enhance the graft-versus-leukemia effectEdwin P Alyea
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2014
Time to reconsider the role of allogeneic transplantation for patients with acute myeloid leukemia and NPM1 mutation?Edwin P Alyea
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 10, 2010
Falling chimerism after reduced intensity conditioning transplantationEdwin P Alyea
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2016
Graft-Versus-Host Disease Prevention: Corticosteroids RevisitedEdwin P Alyea
Hematology. American Society of Hematology. Education Program|February 20, 2015
Maximizing GVL in allogeneic transplantation: role of donor lymphocyte infusionsSarah Nikiforow, Edwin P Alyea
Advances in Pharmacology (San Diego, Calif.)|October 7, 2004
Donor lymphocyte infusionsVincent T Ho, Edwin P Alyea
Current Hematologic Malignancy Reports|February 16, 2015
The evolving role of hematopoietic cell transplantation in chronic lymphocytic leukemiaMatthew S Davids, Edwin P Alyea
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2009
Proteasome inhibition and allogeneic hematopoietic stem cell transplantation: a reviewJohn Koreth, Edwin P Alyea, William J Murphy, et al.
The New England Journal of Medicine|November 8, 2018
Daratumumab for Delayed Red-Cell Engraftment after Allogeneic TransplantationClaudia I Chapuy, Richard M Kaufman, Edwin P Alyea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2009
Graft-versus-host disease of the CNS after allogeneic bone marrow transplantationAli G Saad, Edwin P Alyea, Patrick Y Wen, et al.
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
Best Practice & Research. Clinical Haematology|May 28, 2008
Modulating graft-versus-host disease to enhance the graft-versus-leukemia effectEdwin P Alyea
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2014
Time to reconsider the role of allogeneic transplantation for patients with acute myeloid leukemia and NPM1 mutation?Edwin P Alyea
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 10, 2010
Falling chimerism after reduced intensity conditioning transplantationEdwin P Alyea
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2016
Graft-Versus-Host Disease Prevention: Corticosteroids RevisitedEdwin P Alyea
Hematology. American Society of Hematology. Education Program|February 20, 2015
Maximizing GVL in allogeneic transplantation: role of donor lymphocyte infusionsSarah Nikiforow, Edwin P Alyea
Advances in Pharmacology (San Diego, Calif.)|October 7, 2004
Donor lymphocyte infusionsVincent T Ho, Edwin P Alyea
Current Hematologic Malignancy Reports|February 16, 2015
The evolving role of hematopoietic cell transplantation in chronic lymphocytic leukemiaMatthew S Davids, Edwin P Alyea
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2009
Proteasome inhibition and allogeneic hematopoietic stem cell transplantation: a reviewJohn Koreth, Edwin P Alyea, William J Murphy, et al.
The New England Journal of Medicine|November 8, 2018
Daratumumab for Delayed Red-Cell Engraftment after Allogeneic TransplantationClaudia I Chapuy, Richard M Kaufman, Edwin P Alyea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2009
Graft-versus-host disease of the CNS after allogeneic bone marrow transplantationAli G Saad, Edwin P Alyea, Patrick Y Wen, et al.
Pageof 18